119 related articles for article (PubMed ID: 24217677)
1. Prostate cancer: IMRT treatment rates increase with urologist self-referral.
Phillips R
Nat Rev Urol; 2013 Dec; 10(12):680. PubMed ID: 24217677
[No Abstract] [Full Text] [Related]
2. Joint statement by members of the NCCN Prostate Cancer Guidelines Panel.
Mohler JL;
J Natl Compr Canc Netw; 2013 Nov; 11(11):1310-2. PubMed ID: 24225965
[No Abstract] [Full Text] [Related]
3. Intensity-modulated radiation therapy for prostate cancer.
Jacobs BL; Schroeck FR; Hollenbeck BK
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521127
[No Abstract] [Full Text] [Related]
4. Intensity-modulated radiation therapy for prostate cancer.
Sartor O; Silberstein JL
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521126
[No Abstract] [Full Text] [Related]
5. Intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2014 Feb; 370(7):679-80. PubMed ID: 24521125
[No Abstract] [Full Text] [Related]
6. Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.
Penson DF
J Urol; 2014 May; 191(5):1292. PubMed ID: 24745495
[No Abstract] [Full Text] [Related]
7. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
[TBL] [Abstract][Full Text] [Related]
8. Medicare fee reductions and the overuse of intensity-modulated radiotherapy.
Howard DH; Hockenberry J
Health Serv Res; 2021 Aug; 56(4):626-634. PubMed ID: 33905136
[TBL] [Abstract][Full Text] [Related]
9. US urology clinics overprescribe prostate radiotherapy.
Furlow B
Lancet Oncol; 2011 Feb; 12(2):122. PubMed ID: 21355130
[No Abstract] [Full Text] [Related]
10. Response to "Integrated prostate cancer centers and overutilization of IMRT: a close look at fee-for-service medicine in radiation oncology." (Int J Radiat Oncol Biol Phys 2010;78:1285-1288).
Zimberg SH; Olsson CA
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1607; author reply 1607-8. PubMed ID: 21092840
[No Abstract] [Full Text] [Related]
11. Formation of combined urology and radiation oncology practices: objective data from radiation oncologists for rationale.
Schilling PJ
Am J Clin Oncol; 2011 Jun; 34(3):289-91. PubMed ID: 20805740
[TBL] [Abstract][Full Text] [Related]
12. Adhering to the standard of care for prostate cancer.
Kapoor DA; Penson D
Health Aff (Millwood); 2012 Jun; 31(6):1367; author reply 1367. PubMed ID: 22665854
[No Abstract] [Full Text] [Related]
13. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology.
Falit BP; Gross CP; Roberts KB
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1285-8. PubMed ID: 20338470
[No Abstract] [Full Text] [Related]
14. Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.
Shahinian VB; Kaufman SR; Yan P; Herrel LA; Borza T; Hollenbeck BK
Medicine (Baltimore); 2017 Jun; 96(25):e6929. PubMed ID: 28640073
[TBL] [Abstract][Full Text] [Related]
15. Changes in urology standard of care.
Plandowski JW
Health Aff (Millwood); 2012 Jun; 31(6):1367; author reply 1367. PubMed ID: 22665853
[No Abstract] [Full Text] [Related]
16. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
[TBL] [Abstract][Full Text] [Related]
17. Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection.
Mitchell JM
Health Aff (Millwood); 2012 Apr; 31(4):741-9. PubMed ID: 22492891
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.
Riou O; Regnault de la Mothe P; Azria D; Aillères N; Dubois JB; Fenoglietto P
J Appl Clin Med Phys; 2013 Jul; 14(4):4094. PubMed ID: 23835376
[TBL] [Abstract][Full Text] [Related]
19. Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer.
Hall WA; Fox TH; Jiang X; Prabhu RS; Rossi PJ; Godette K; Jani AB
J Am Coll Radiol; 2013 Feb; 10(2):128-34. PubMed ID: 23245437
[TBL] [Abstract][Full Text] [Related]
20. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse.
Jacobs BL; Zhang Y; Skolarus TA; Hollenbeck BK
Health Aff (Millwood); 2012 Apr; 31(4):750-9. PubMed ID: 22492892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
